Apple Inc sold US$1.38 billion of US dollar-denominated bonds in Taiwan, while Canada’s Manulife Financial Corp also priced US$1 billion of securities, as such debt offerings jump amid demand from insurers.
The sales bring issuance of such corporate securities to US$23 billion for the year, up by 53 percent from the same period last year, data compiled by Bloomberg showed.
Domestic life insurers looking for higher yields are driving the trend, said Lawrence Lai (賴星旅), Asia rates strategist at Standard Chartered PLC.
Apple’s 30-year note has a 4.15 percent coupon and Manulife’s bond with the same maturity has a 4.7 percent coupon.
Such multi-decade debentures also suit the needs of life insurers, which must make longer-term investments, Lai said.
FLOODGATES OPENED
A regulatory change in 2014 opened the floodgates for about US$600 billion of life insurance assets in Taiwan to invest more freely in foreign-currency bonds. Since then, global issuers including Goldman Sachs Group Inc have sold almost US$80 billion in US dollar debt to Taiwanese life insurers.
The largest offering in the nation’s market for bonds in foreign currencies was AT&T Inc, which raised US$2.62 billion last year.
“At the beginning there were more financials, but life insurers do not really want to hold more financials,” Lai said. “Now the mix is healthier.”
DEBT AVOIDED
As yields have fallen at home, life insurers in Taiwan have avoided local debt in favor of foreign notes with higher yields.
For the first time since 2008, life insurers did not buy any 20-year government bonds in an April sale. Instead, banks picked up the notes at a record-low 1.36 percent yield.
Financial Supervisory Commission Chairman Ding Kung-wha (丁克華) said in an interview last month that, although he was concerned about exchange rate and other risks associated with the US$300 billion of life insurance funds invested in foreign currency assets, he was not in favor of closing the spigot.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained